Delcath Systems Inc

NASDAQ:DCTH   1:00:00 PM EDT
12.69
+0.18 (+1.44%)
4:38:10 PM EDT: $12.95 +0.26 (+2.05%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)441.95M
Current PEN/A
Forward PE 423
2yr Forward PE 20.14
See more stats
Estimates Current Quarter
Revenue$22.94 Million
Adjusted EPS$0.03
See more estimates
10-Day MA$13.46
50-Day MA$14.61
200-Day MA$12.65
See more pivots

Delcath Systems Inc Stock, NASDAQ:DCTH

566 Queensbury Avenue, Suite 22C, Queensbury, New York 12804
United States of America
Phone: +1.212.489.2100
Number of Employees: 96

Description

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.